Better MRI imaging for meningioma
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a new type of MRI scan that may help see meningioma brain tumors more clearly. It is a short imaging study for people who plan to have surgery or monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a meningioma (a type of brain tumor) that is at least 1 cm wide and shows up on an MRI.
- You are at least 18 years old and able to have an MRI scan safely.
- You are expected to live longer than 12 weeks and are in fairly good health (can take care of yourself).
- Your kidney function is normal, based on a recent blood test.
- You are not pregnant or breastfeeding, and are willing to use birth control if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a special MRI technique called 3D MRE (magnetic resonance elastography) to measure how stiff a meningioma tumor is. The goal is to see if the stiffness can help predict the tumor’s type and characteristics before surgery.
This trial tests a type of radiation (protons) for brain tumors called atypical or anaplastic meningiomas that need radiotherapy. It may help by aiming radiation more precisely while also learning the safest and most effective dose.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This early-phase study tests whether a special MRI scan with injected labeled “pyruvate” can act as a biomarker (a measurable sign) for advanced solid tumor activity. It may help doctors see tumor metabolism over time and better track how treatment is affecting cancer.
This Phase 1 study uses special MRI scans (including a form of MR spectroscopy) to better understand lower-grade gliomas. It is designed to test how well the imaging can “characterize” the tumor and to improve understanding for treatment planning.
This early-phase study tests a special MRI scan using C-13 pyruvate to help identify and understand gliomas (a type of brain tumor) in people with brain tumors going to surgery or biopsy. It may help doctors see tumor signals better before or around the time of your procedure.
Hear when a new Meningioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.